Davis's Drug Guide
gemcitabine
General
High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.
Pronunciation:
jem-site-a-been
To hear audio pronunciation of this topic, purchase a subscription or log in.Trade Name(s)
- Avgemsi
- Gemzar
Ther. Class.
Pharm. Class.
antimetabolites
nucleoside analogues
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., and Cynthia A. Sanoski. "Gemcitabine." Davis's Drug Guide, 20th ed., F.A. Davis Company, 2026. The Washington Manual, www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/51352/9/gemcitabine.
Vallerand AHA, Sanoski CAC. Gemcitabine. Davis's Drug Guide. F.A. Davis Company; 2026. https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/51352/9/gemcitabine. Accessed June 25, 2026.
Vallerand, A. H., & Sanoski, C. A. (2026). Gemcitabine. In Davis's Drug Guide (20th ed.). F.A. Davis Company. https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/51352/9/gemcitabine
Vallerand AHA, Sanoski CAC. Gemcitabine [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 June 25]. Available from: https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/51352/9/gemcitabine.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - gemcitabine
ID - 51352
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/51352/9/gemcitabine
PB - F.A. Davis Company
ET - 20
DB - The Washington Manual
DP - Unbound Medicine
ER -
